Last reviewed · How we verify
L-menthol
At a glance
| Generic name | L-menthol |
|---|---|
| Also known as | Peppermint oil |
| Sponsor | Region Skane |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease (PHASE2)
- Abuse Liability for Four Heated Tobacco Product (HTP) Consumables and Two HTP Devices (NA)
- Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease (PHASE2)
- Menthol for Dyspnea Relief in Health and COPD (NA)
- Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1 (EARLY_PHASE1)
- Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch (NA)
- The Effect of Probiotic Lactobacillus Reuteri Prodentis Consumption on Gingival Crevicular Fluid Inflammatory Response and Metagenomic Profiles of Oral Microbiome in Orthodontic Patients. (NA)
- L-Menthol Injection as a Novel Technique During Colonoscopy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |